Tango Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
TNGX Nasdaq 2830 www.tangotx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tango Therapeutics, Inc.

This Biotech ETF Has Almost Doubled in 13 Months. Money Is Flowing In. - Jun 26th, 2026 1:38 pm
Tango Therapeutics Appoints Robert Azelby to Board of Directors - Jun 22nd, 2026 2:05 pm
Daraxonrasib’s Phase 3 Pancreatic Cancer Survival Data Might Change The Case For Investing In RVMD - Jun 11th, 2026 6:23 pm
Is Tango Therapeutics (TNGX) Price Justified After Its 7x Surge In One Year - Jun 10th, 2026 2:10 am
Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering - Jun 9th, 2026 8:49 pm
TNGX Stock Jumps 53% on Early Pancreatic Cancer Study Results - Jun 9th, 2026 10:44 am
Tango Therapeutics stock surges on pancreatic cancer trial data - Jun 9th, 2026 7:31 am
Tango Therapeutics (TNGX) Stock Soars on Pancreatic Cancer Trial Results - Jun 9th, 2026 7:29 am
Tango Therapeutics Stock Soars 53% After ’Unprecedented’ Data on Pancreatic Cancer Treatment - Jun 8th, 2026 2:08 pm
Tango Skyrockets On Eye-Popping Pancreatic Cancer Results - Jun 8th, 2026 2:05 pm
Tango Therapeutics Announces Proposed $500 Million Public Offering - Jun 8th, 2026 2:01 pm
Sector Update: Healthcare Stocks Decline Late Afternoon - Jun 8th, 2026 1:48 pm
Top Midday Gainers - Jun 8th, 2026 11:58 am
TNGX Stock Hits All-Time High – Wolfe Research Calls Tango Therapeutic’s Pancreatic Cancer Trial Data ‘Groundbreaking’ - Jun 8th, 2026 11:44 am
Top Midday Stories: US Weighs Financial Stakes in AI Firms; Google, Nvidia Turn to Intel as TSMC Struggles With Demand - Jun 8th, 2026 9:43 am
Tango Therapeutics Says Initial Results From Phase 1/2 Trial of Pancreatic Cancer Drug Candidate Showed Improvement in Survival Rate; Shares Rise Pre-Bell - Jun 8th, 2026 6:03 am
Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer - Jun 8th, 2026 4:59 am
Tango Therapeutics (TNGX) Could Benefit From Pancreatic Ductal Adenocarcinoma Data Announcement - Jun 5th, 2026 9:55 am
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jun 5th, 2026 5:00 am
Here is Why Erasca (ERAS) is One of the Best Growth Stocks Under $20 - Jun 3rd, 2026 11:59 am